Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice
- PMID: 11512092
- DOI: 10.1086/322698
Strategies for optimizing adherence to highly active antiretroviral therapy: lessons from research and clinical practice
Abstract
Successful treatment of human immunodeficiency virus infection/acquired immunodeficiency syndrome (HIV/AIDS) with highly active antiretroviral therapy (HAART) requires that patients maintain nearly perfect adherence to the prescribed regimen. Suboptimal adherence to antiretroviral therapy is clearly the most common cause of virologic failure of HAART regimens. Given the critical role of adherence in successful antiretroviral therapy, it is essential that providers of care for patients with HIV infection have a strategy that proactively assists and supports their patients' efforts to adhere to medication regimens. This review endeavors to provide a clinically focused approach to optimizing adherence of patients to HAART.
Similar articles
-
Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Verh K Acad Geneeskd Belg. 2001. PMID: 11813503 Review.
-
Challenges of adherence management in human immunodeficiency virus pharmacotherapy.Can J Clin Pharmacol. 2003 Winter;10(4):189-95. Can J Clin Pharmacol. 2003. PMID: 14712324 Review.
-
The decision to forgo antiretroviral therapy in people living with HIV compliance as paternalism or partnership?Eur J Med Res. 2004 Feb 27;9(2):61-70. Eur J Med Res. 2004. PMID: 15090291
-
Strategies for improving patient adherence to therapy and long-term patient outcomes.J Assoc Nurses AIDS Care. 2007 Jan-Feb;18(1 Suppl):S17-22. doi: 10.1016/j.jana.2006.11.020. J Assoc Nurses AIDS Care. 2007. PMID: 17275718
-
[Adherence to antiretroviral therapy during HIV infection, a multidisciplinary approach].Med Mal Infect. 2006 Jan;36(1):16-26. doi: 10.1016/j.medmal.2005.10.003. Epub 2005 Dec 1. Med Mal Infect. 2006. PMID: 16325363 Review. French.
Cited by
-
Physician contributions to disparities in HIV/AIDS care: the role of provider perceptions regarding adherence.Curr HIV/AIDS Rep. 2005 Nov;2(4):189-93. doi: 10.1007/s11904-005-0015-5. Curr HIV/AIDS Rep. 2005. PMID: 16343377 Review.
-
Study the drug adherence and possible factor influencing drug adherence in HIV/AIDS patients in north eastern part of India.J Educ Health Promot. 2014 May 3;3:31. doi: 10.4103/2277-9531.131898. eCollection 2014. J Educ Health Promot. 2014. PMID: 25013824 Free PMC article.
-
How does decision complexity affect shared decision making? An analysis of patient-provider antiretroviral initiation dialogue.Patient Educ Couns. 2017 May;100(5):919-926. doi: 10.1016/j.pec.2016.12.013. Epub 2016 Dec 16. Patient Educ Couns. 2017. PMID: 28012679 Free PMC article.
-
Efficacy of directly observed treatment of HIV infection: experience in AIDS welfare homes.Eur J Clin Microbiol Infect Dis. 2004 Apr;23(4):331-5. doi: 10.1007/s10096-003-1099-8. Epub 2004 Mar 13. Eur J Clin Microbiol Infect Dis. 2004. PMID: 15024621
-
Pharmacokinetics, food intake requirements and tolerability of once-daily combinations of nelfinavir and low-dose ritonavir in healthy volunteers.Br J Clin Pharmacol. 2003 Feb;55(2):115-25. doi: 10.1046/j.1365-2125.2003.01756.x. Br J Clin Pharmacol. 2003. PMID: 12580982 Free PMC article. Clinical Trial.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical